Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microneedling vs Tazarotene for Atrophic Acne Scars
NCT03170596Completed
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Jun 2017
- Primary completion
- Feb 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, single-blind trial of tazarotene in Atrophic acne scarring (2 arms), sponsored by Post Graduate Institute of Medical Education and Research. Primary endpoint: Acne scar severity grade (Goodman's Qualitative classification) at 6 months. Started Jun 2017; status: completed.
02
Drugs
tazarotene
03
Conditions
Atrophic acne scarring
Beyond the preview
Go deeper on NCT03170596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03170596.